Latest Breaking News On - Digital therapeutics programs - Page 1 : vimarsana.com

Digital Therapeutics (DTx) Market Report 2022: Unexplored Therapeutic Applications Presents Opportunities

/PRNewswire/ The "Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse,.

United statesLaura woodTeladoc healthBehavr incKaia healthOmada healthMindstrong healthOffice hours callResearch methodologyPropeller healthCompany profilesE st office hours callVirta health corpMindable healthCanary healthSubstance abuse

Digital Therapeutics (DTx) Market Report 2022: Significant

Dublin, Nov. 17, 2022 (GLOBE NEWSWIRE) The "Digital Therapeutics (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD,.

United statesTeladoc healthBehavr incKaia healthOmada healthMindstrong healthResearch methodologyPropeller healthCompany profilesVirta health corpMindable healthCanary healthSubstance abusePreventable chronicControl healthcareVenture capital

Global Digital Therapeutics (DTx) Markets, 2021-2026: Growing Cross-Industry Collaborations Between Digital Therapeutics Start-Ups and Pharmaceutical Companies to Drive Market Growth

Global Digital Therapeutics (DTx) Markets, 2021-2026: Growing Cross-Industry Collaborations Between Digital Therapeutics Start-Ups and Pharmaceutical Companies to Drive Market Growth
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLaura woodKaia healthBehavr incOmada healthMindstrong healthAyogo healthLivongo healthMorrow incAkili interactive labs incCompany evaluation matrixTechnology trendsPorter five forces analysisMango health incOffice hours call

Wellocity Health Announces Appointment of New Advisors

Wellocity Health Announces Appointment of New Advisors Share Article To accelerate the growth of Wellocity’s Telehealth platform for Disease Prevention Programs. The Wellocity platform for personalized lifestyle change is designed to mitigate barriers, strengthen existing programs and improve participation in evidence-based programming. SAN FRANCISCO (PRWEB) December 17, 2020 Wellocity Health, a Telehealth platform company that powers the delivery of Digital Therapeutics Programs for evidence-based personalized lifestyle change focused on preventing diabetes and heart disease, recently announced the addition of two new advisors. Alon Gitig, M.D., F.A.C.C., a Preventive Cardiologist and Medical Director at Mount Sinai Health System, and Elizabeth Hawk MS, RDN, CDE at Penn State Health St. Joseph, have joined Wellocity’s advisory board.

United statesSameer kanagalaElizabeth hawkWellocity healthPenn state health stNational diabetes prevention programMount sinai health systemEducation specialist at penn state health stDigital therapeutics programsPreventive cardiologistMedical directorPenn state healthHeart failure disease management programMount sinai doctorsCertified diabetes careEducation specialist